AFC-HD AMS Life Science Co

AFC-HD AMS Life Science Co Interest Coverage

The Interest Coverage Ratio of AFC-HD AMS Life Science Co (2927.T) as of Nov 4, 2026 is 24.92. In the previous year, Interest Coverage Ratio was 375.28 — a change of -93.36% (lower).

Interest Coverage

24.92

YoY

-93.36%

Last updated:

Interest Coverage Ratio of AFC-HD AMS Life Science Co is 2025 24.92 . Interest Coverage Ratio of AFC-HD AMS Life Science Co was 2024 375.28 . It decreases by -93.36% lower compared to the previous year.

The AFC-HD AMS Life Science Co Interest Coverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Interest Coverage
Date
Interest Coverage
Jan 1, 2018
26.06 JPY
Jan 1, 2019
169.18 JPY
Jan 1, 2020
88.36 JPY
Jan 1, 2021
58.34 JPY
Jan 1, 2022
39.02 JPY
Jan 1, 2023
302.57 JPY
Jan 1, 2024
375.28 JPY
Jan 1, 2025
24.92 JPY
The AFC-HD AMS Life Science Co Interest Coverage history
YEARInterest CoverageYoY
24.92-93.36%
375.28+24.03%
302.57+675.33%
39.02-33.11%
58.34-33.97%
88.36-47.78%
169.18+549.13%
26.06+3.88%
25.09+118.62%
11.48-60.47%
29.03+285.73%
7.53—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

AFC-HD AMS Life Science Co Stock analysis

What does AFC-HD AMS Life Science Co do? AFC-HD AMS Life Science Co., Ltd. generates revenue through its Healthcare segment, which produces and sells health foods, cosmetics, and OEM services for other brands. The Pharmaceutical segment manufactures and sells ethical drugs, over-the-counter drugs, and generic medicines. The company also manages restaurants via a subsidiary, contributing to its diversified income streams. Customers include businesses seeking OEM partnerships and consumers purchasing health and pharmaceutical products. The firm's products are sold under its own brand and through OEM agreements, targeting both individual consumers and corporate clients. The Healthcare segment focuses on wellness products, while the Pharmaceutical segment caters to medical needs with prescription and non-prescription drugs. The restaurant management subsidiary provides additional revenue from food service operations. Revenue is derived from the sale of health foods, cosmetics, Chinese medicine medicines, general medicines, and healthcare products within the Healthcare segment. The Pharmaceutical segment's income comes from ethical drugs, over-the-counter drugs, and generic medicines. The restaurant subsidiary's operations further support the company's financial structure through food service sales. AFC-HD AMS Life Science Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about AFC-HD AMS Life Science Co stock

Interest Coverage Ratio of AFC-HD AMS Life Science Co is 24.92 in 2025.

Interest Coverage Ratio of AFC-HD AMS Life Science Co changed from 375.28 to 24.92, representing a -93.36% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Interest Coverage Ratio AFC-HD AMS Life Science Co since 2006 – with annual values, charts, and detailed analysis.

The Interest Coverage ratio measures a company's ability to pay interest on its debt. Higher ratios indicate greater financial strength and lower default risk.

Interest Coverage = EBIT / Interest Expense

A 'good' varies by industry and company stage. On Eulerpool, you can compare Interest Coverage Ratio's AFC-HD AMS Life Science Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — AFC-HD AMS Life Science Co

All Key Metrics — AFC-HD AMS Life Science Co